Hidemichi Watari

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.9K citations

Pharmacy, Oncology, Pharmacotherapy +14

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

Yukiharu Todo, Hidenori Kato, Masanori Kaneuchi et al. · The Lancet · 2010 · 773 citations

Medicine, Oncology, Surgery +12

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 416 citations · Full text

Medicine, Oncology, Pharmacology +15

Phosphorylation of Steroidogenic Acute Regulatory Protein (StAR) Modulates Its Steroidogenic Activity

Futoshi Arakane, Steven R. King, Yang Du et al. · Journal of Biological Chemistry · 1997 · 382 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

Peixin Dong, Mihriban Karaayvaz, Nan Jia et al. · Oncogene · 2012 · 305 citations · Full text

Medicine, Molecular Biology, Oncology +17